Skip to main content

Zecyte tablet |Abiraterone acetate | apple pharmaceuticals

Zecyte 500mg

         Abiraterone is sold under brand name Zecyte 500mg is belongs to type of anti-cancer medication that will act by decline the androgen production in the body. Androgen is a male hormone that can maintained the tumor cell in prostate glands. This drug is given by co administration with prednisolone, a steroid which reduce the liability of side effects produced by Abiraterone.

DOSAGE     

        The prescribed dose of Zecyte is initial as 4 tablets given orally once daily. The drug Zecyte administrated combination with 5mg prednisolone twice daily in empty stomach. Zecyte Tablets given on an empty stomach.  Food should not be taken for at least 2 hours before and at least 1 hour after the dose of Zecyte 500mg Tablets is taken. Swallowed whole with water. Chew the tablets or Do not crush


MECHANISM OF ACTION

           Androgens are balance the production of malignant in prostate.Zecyte 500mg belongs to anti androgen drugs, that causes to suppress the enzyme 17α-hydroxylase C 17, 20-lyase (CYP17), it is involving in androgen conglomerate.Reduce the serum testosterone level. Declined the tumor cell occurred.

zecyte 500mg
zecyte 500mg

PHARMACOKINETICS


Absorption:  Time to maximum plasma concentration of Zecyte 500mg tablet takes 12 hours.
Distribution: Maximum bound to the human plasma protein like albumin and alpha-1 acid glycoprotein.
Metabolism: The main two metabolites of Abiraterone in human plasma are Abiraterone sulphate and N-oxide Abiraterone sulphate.
Excretion: The drug mainly excreted in 88% feces and 5% in urine
Half-life of tablet Zecyte 500mg is 12 ± 5 hours.


SAFETY AND WARNING


        Any allergy, serious liver problem or pregnant in patient, Zecyte 500mg therapy should be stopped Avoid taking of other medications, i.e. prescription, over-the-counter, vitamins, herbal remedies, etc. be sure to inform the doctors before the treatment.
Do not take Aspirin administrated and products containing aspirin till doctor particularly allow the drug.

DRUG INTERACTION


         Interaction of Zecyte 500mg with dextromethorphan will raises the Cmax and AUC of dextromethorphan Interaction Zecyte 500mg with strong CYP3A inhibitors or inducers, concomitant use with caution because pharmacokinetics is not evaluated.

STORAGE

         The drug stored at 15℃-30℃ Keep the drug in dry place.


MISSED DOSE

         If patient missed the dose of Zecyte 500mg, that missed dose will be skipped and follow the regular dosing schedule.

zecyte 500mg tablet
zecyte 500mg tablet

SIDE EFFECTS


Common effects:

          Fatigue, Arthralgia, Hypertension, Nausea, edema, Hypokalemia, Diarrhea, vomiting, Cough, headache, Glucocorticoid deficiency, Mineral corticoid deficiency, Hepatotoxicity, Hypertension, Decrease in ka level, Adrenocortical insufficiency Muscular skeletal and Connective tissue disorders: Joint swelling, discomfort, muscle discomfortGeneral Disorder: EdemaCardiac disorders: Hot flush, hypertension, arrhythmias, chest pain, cardiac failureGIT disorders: Diarrhea, dyspepsia
Infections and Infestation: UTI Pulmonary disorder: Cough Renal: Urinary frequency, nocturia
Injuries: Fractures.


OVERDOSAGE

           Zecyte 500mg has no essential antidote, If overdose occurs end treatment with the drug and give general supportive measures such as monitoring arrhythmias and cardiac failure and assess liver function.

Phone Number

+91-9987711567

URL

Email ID
applepharmaceutical@gmail.com
info@myapplepharma.com

Comments

Popular posts from this blog

Comprar Tagrisso 80mg | Precio Tagrisso 80mg medicina

DESCRIPCIÓN Una tableta de Tagrisso de 80 mg contiene un principio activo conocido como Osimeritinib, que antes se conocía como Mereletinib.Tagrisso 80 mg está considerado como medicamento de tercera generación, que está disponible en forma de tableta.Tagrisso 80 mg es un inhibidor inevitable del receptor del factor de crecimiento epidérmico, desviado de manera selectiva, que contiene actividad anticancerígena. La categoría farmacológica de Tagrisso 80mg es tirosina quinasa prohibitor. INDICACIÓN Un comprimido de Tagrisso 80 mg (osimertinib) está ampliamente indicado como tratamiento de primera línea para el cáncer de pulmón no microcítico avanzado con pacientes con mutación EGFR positiva.Tagrisso 40mgi s también se utiliza para el tratamiento de pacientes afectados con una mutación positiva de EGFR T792M NSCLC, la enfermedad ha avanzado en o después del tratamiento con inhibidores de la tirosina quinasa.Usos en Embarazo, lactancia, pediatría: No se asigna la categoría de embara

Trastuzumab - Biceltis 440mg injection online | Myapplepharma

Biceltis 440 mg Injection             Biceltis 440mg is a group of medicines which belongs to anti neoplastic medication. Biceltis is a chemotherapy drug. It is recommended that Biceltis 440mg be administered under the guidance of a qualified physician experienced in the use of cancer chemotherapeutic agents. USES           The injection Biceltis 440mg is used alone or combination with other medicine for the treatment in patients who suffering from metastatic breast cancer.           The drug also indicated with combination of other medicine for the treatment of certain types of stomach or esophagus cancer in some persons. WORK AS         Different type of breast cancer cells has a higher than normal level of a protein called HER2 (human epidermal growth factor receptor 2) on their surface. These HER2 receptors get signals which stimulate the tumor cells to develop and reproduce. But breast cancer cells with too many HER2 receptors can Choice too many growth signa

Купить Erlonat 150 | Erlonat 150 цена 150 $

ОПИСАНИЕ Erlonat 150мг  таблетки состоят из активных ингредиентов, известных как Erlotinib (Generic Tarceva) , который считается производным хиназолина и противораковые агенты, которые отвечают как ингибиторы протеинкиназы на EGFR, связанные с тирозинкиназой. Erlonat 150мг в основном используется в лечение немелкоклеточного рака легких и рака поджелудочной железы, а также участие в лечении различных видов рака. Эрлонат особенно нацелен эпидермальный фактор роста, рецепторная тирозинкиназа. ИСПОЛЬЗОВАНИЕ Erlonat Немелкоклеточный рак легких: Эрлонат показан в качестве продолжения терапии у пациентов с длительной или метастазирующей немелкоклеточной карциномой легкого, чье заболевание имеет не получить аванс после четырех циклов терапии с использованием первой линии на основе платины. Erlonat используется в этом состоянии только после отказа одного из предыдущих режим химиотерапии. При использовании Erlonat 150мг с такими соединениями на основе платины, как карбоплатин, гемцитаби